Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for AGCAGCA
Z-value: 1.21
Motif logo
miRNA associated with seed AGCAGCA
| Name | miRBASE accession |
|---|---|
|
hsa-miR-15a-5p
|
MIMAT0000068 |
|
hsa-miR-15b-5p
|
MIMAT0000417 |
|
hsa-miR-16-5p
|
MIMAT0000069 |
|
hsa-miR-195-5p
|
MIMAT0000461 |
|
hsa-miR-424-5p
|
MIMAT0001341 |
|
hsa-miR-497-5p
|
MIMAT0002820 |
|
hsa-miR-6838-5p
|
MIMAT0027578 |
Activity profile of AGCAGCA motif
Sorted Z-values of AGCAGCA motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chrX_+_64708615 | 21.77 |
ENST00000338957.4
ENST00000423889.3 |
ZC3H12B
|
zinc finger CCCH-type containing 12B |
| chr20_+_10199468 | 20.01 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
| chr2_+_149632783 | 19.22 |
ENST00000435030.1
|
KIF5C
|
kinesin family member 5C |
| chr2_+_113033164 | 17.76 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
| chr9_+_17579084 | 15.53 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
| chr3_+_10206545 | 15.03 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
| chr17_+_57232690 | 13.29 |
ENST00000262293.4
|
PRR11
|
proline rich 11 |
| chr6_+_107811162 | 12.70 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
| chr8_-_42397037 | 12.14 |
ENST00000342228.3
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
| chr11_+_113930291 | 11.79 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
| chr9_-_95432536 | 11.74 |
ENST00000287996.3
|
IPPK
|
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
| chr1_+_46668994 | 11.16 |
ENST00000371980.3
|
LURAP1
|
leucine rich adaptor protein 1 |
| chr17_+_40834580 | 10.79 |
ENST00000264638.4
|
CNTNAP1
|
contactin associated protein 1 |
| chrX_+_53111541 | 10.67 |
ENST00000375442.4
ENST00000579390.1 |
TSPYL2
|
TSPY-like 2 |
| chrX_-_50557014 | 10.66 |
ENST00000376020.2
|
SHROOM4
|
shroom family member 4 |
| chr17_+_30813576 | 10.64 |
ENST00000313401.3
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
| chr6_+_71122974 | 10.41 |
ENST00000418814.2
|
FAM135A
|
family with sequence similarity 135, member A |
| chr19_-_17799008 | 10.36 |
ENST00000519716.2
|
UNC13A
|
unc-13 homolog A (C. elegans) |
| chr3_-_57678772 | 10.35 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
| chr16_+_19125252 | 9.93 |
ENST00000566735.1
ENST00000381440.3 |
ITPRIPL2
|
inositol 1,4,5-trisphosphate receptor interacting protein-like 2 |
| chr11_+_124492749 | 9.68 |
ENST00000531667.1
ENST00000441174.3 ENST00000375005.4 |
TBRG1
|
transforming growth factor beta regulator 1 |
| chr7_+_4721885 | 9.63 |
ENST00000328914.4
|
FOXK1
|
forkhead box K1 |
| chr6_+_142468361 | 9.63 |
ENST00000367630.4
|
VTA1
|
vesicle (multivesicular body) trafficking 1 |
| chr12_-_112819896 | 9.60 |
ENST00000377560.5
ENST00000430131.2 ENST00000550722.1 ENST00000550724.1 |
HECTD4
|
HECT domain containing E3 ubiquitin protein ligase 4 |
| chr5_+_140306478 | 9.40 |
ENST00000253807.2
|
PCDHAC1
|
protocadherin alpha subfamily C, 1 |
| chr5_+_157170703 | 9.40 |
ENST00000286307.5
|
LSM11
|
LSM11, U7 small nuclear RNA associated |
| chr6_-_136871957 | 9.24 |
ENST00000354570.3
|
MAP7
|
microtubule-associated protein 7 |
| chr5_+_140213815 | 9.23 |
ENST00000525929.1
ENST00000378125.3 |
PCDHA7
|
protocadherin alpha 7 |
| chrX_-_54384425 | 9.20 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
| chr4_-_153457197 | 9.10 |
ENST00000281708.4
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
| chr1_+_52870227 | 8.95 |
ENST00000257181.9
|
PRPF38A
|
pre-mRNA processing factor 38A |
| chr5_+_140254884 | 8.91 |
ENST00000398631.2
|
PCDHA12
|
protocadherin alpha 12 |
| chr5_+_175792459 | 8.82 |
ENST00000310389.5
|
ARL10
|
ADP-ribosylation factor-like 10 |
| chr2_-_70418032 | 8.75 |
ENST00000425268.1
ENST00000428751.1 ENST00000417203.1 ENST00000417865.1 ENST00000428010.1 ENST00000447804.1 ENST00000264434.2 |
C2orf42
|
chromosome 2 open reading frame 42 |
| chr19_-_5978090 | 8.71 |
ENST00000592621.1
ENST00000034275.8 ENST00000591092.1 ENST00000591333.1 ENST00000590623.1 ENST00000439268.2 ENST00000587159.1 |
RANBP3
|
RAN binding protein 3 |
| chr1_-_57045228 | 8.66 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
| chr7_+_95401851 | 8.65 |
ENST00000447467.2
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr10_+_92980517 | 8.52 |
ENST00000336126.5
|
PCGF5
|
polycomb group ring finger 5 |
| chr7_+_138916231 | 8.50 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
| chr17_-_79139817 | 8.34 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
| chr5_+_140220769 | 8.26 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
| chr20_+_34700333 | 8.22 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr17_-_29624343 | 8.19 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
| chr1_+_78245303 | 8.14 |
ENST00000370791.3
ENST00000443751.2 |
FAM73A
|
family with sequence similarity 73, member A |
| chr12_-_6580094 | 8.03 |
ENST00000361716.3
|
VAMP1
|
vesicle-associated membrane protein 1 (synaptobrevin 1) |
| chr1_-_52831796 | 7.99 |
ENST00000284376.3
ENST00000438831.1 ENST00000371586.2 |
CC2D1B
|
coiled-coil and C2 domain containing 1B |
| chr1_+_10271674 | 7.86 |
ENST00000377086.1
|
KIF1B
|
kinesin family member 1B |
| chr13_-_30881621 | 7.86 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
| chr2_-_37193606 | 7.83 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
| chr5_+_140248518 | 7.62 |
ENST00000398640.2
|
PCDHA11
|
protocadherin alpha 11 |
| chr7_-_103629963 | 7.60 |
ENST00000428762.1
ENST00000343529.5 ENST00000424685.2 |
RELN
|
reelin |
| chr11_+_46639071 | 7.48 |
ENST00000580238.1
ENST00000581416.1 ENST00000529655.1 ENST00000533325.1 ENST00000581438.1 ENST00000583249.1 ENST00000530500.1 ENST00000526508.1 ENST00000578626.1 ENST00000577256.1 ENST00000524625.1 ENST00000582547.1 ENST00000359513.4 ENST00000528494.1 |
ATG13
|
autophagy related 13 |
| chr16_+_1662326 | 7.37 |
ENST00000397412.3
|
CRAMP1L
|
Crm, cramped-like (Drosophila) |
| chr10_-_120514720 | 7.37 |
ENST00000369151.3
ENST00000340214.4 |
CACUL1
|
CDK2-associated, cullin domain 1 |
| chr4_-_76944621 | 7.24 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
| chr14_-_23822080 | 7.23 |
ENST00000397267.1
ENST00000354772.3 |
SLC22A17
|
solute carrier family 22, member 17 |
| chr11_+_14665263 | 7.22 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
| chr2_+_203879568 | 7.20 |
ENST00000449802.1
|
NBEAL1
|
neurobeachin-like 1 |
| chr4_+_7045042 | 7.15 |
ENST00000310074.7
ENST00000512388.1 |
TADA2B
|
transcriptional adaptor 2B |
| chr1_+_180601139 | 7.12 |
ENST00000367590.4
ENST00000367589.3 |
XPR1
|
xenotropic and polytropic retrovirus receptor 1 |
| chr6_-_154831779 | 7.08 |
ENST00000607772.1
|
CNKSR3
|
CNKSR family member 3 |
| chr11_+_92085262 | 6.99 |
ENST00000298047.6
ENST00000409404.2 ENST00000541502.1 |
FAT3
|
FAT atypical cadherin 3 |
| chr7_-_44924939 | 6.94 |
ENST00000395699.2
|
PURB
|
purine-rich element binding protein B |
| chr11_-_117186946 | 6.89 |
ENST00000313005.6
ENST00000528053.1 |
BACE1
|
beta-site APP-cleaving enzyme 1 |
| chr16_+_50775948 | 6.83 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
| chr13_+_58206655 | 6.82 |
ENST00000377918.3
|
PCDH17
|
protocadherin 17 |
| chr15_+_43803143 | 6.79 |
ENST00000382031.1
|
MAP1A
|
microtubule-associated protein 1A |
| chr5_+_140227048 | 6.79 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
| chr14_-_77843390 | 6.77 |
ENST00000216468.7
|
TMED8
|
transmembrane emp24 protein transport domain containing 8 |
| chr19_-_18632861 | 6.71 |
ENST00000262809.4
|
ELL
|
elongation factor RNA polymerase II |
| chr15_+_41851211 | 6.66 |
ENST00000263798.3
|
TYRO3
|
TYRO3 protein tyrosine kinase |
| chr20_+_24449821 | 6.60 |
ENST00000376862.3
|
SYNDIG1
|
synapse differentiation inducing 1 |
| chr2_-_2334888 | 6.48 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
| chr3_+_52489503 | 6.40 |
ENST00000345716.4
|
NISCH
|
nischarin |
| chr5_+_140345820 | 6.39 |
ENST00000289269.5
|
PCDHAC2
|
protocadherin alpha subfamily C, 2 |
| chr18_-_65184217 | 6.34 |
ENST00000310045.7
|
DSEL
|
dermatan sulfate epimerase-like |
| chr16_+_30710462 | 6.30 |
ENST00000262518.4
ENST00000395059.2 ENST00000344771.4 |
SRCAP
|
Snf2-related CREBBP activator protein |
| chr1_-_41131326 | 6.25 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
| chr1_-_207224307 | 6.24 |
ENST00000315927.4
|
YOD1
|
YOD1 deubiquitinase |
| chr3_-_120068143 | 6.22 |
ENST00000295628.3
|
LRRC58
|
leucine rich repeat containing 58 |
| chr5_+_172483347 | 6.15 |
ENST00000522692.1
ENST00000296953.2 ENST00000540014.1 ENST00000520420.1 |
CREBRF
|
CREB3 regulatory factor |
| chr5_-_132299313 | 6.13 |
ENST00000265343.5
|
AFF4
|
AF4/FMR2 family, member 4 |
| chr1_-_115212696 | 6.10 |
ENST00000393276.3
ENST00000393277.1 |
DENND2C
|
DENN/MADD domain containing 2C |
| chr10_-_11653753 | 6.05 |
ENST00000609104.1
|
USP6NL
|
USP6 N-terminal like |
| chr3_+_183903811 | 5.94 |
ENST00000429586.2
ENST00000292808.5 |
ABCF3
|
ATP-binding cassette, sub-family F (GCN20), member 3 |
| chr1_+_184356188 | 5.91 |
ENST00000235307.6
|
C1orf21
|
chromosome 1 open reading frame 21 |
| chr16_+_67927147 | 5.89 |
ENST00000291041.5
|
PSKH1
|
protein serine kinase H1 |
| chr16_+_70148230 | 5.88 |
ENST00000398122.3
ENST00000568530.1 |
PDPR
|
pyruvate dehydrogenase phosphatase regulatory subunit |
| chr11_-_74109422 | 5.82 |
ENST00000298198.4
|
PGM2L1
|
phosphoglucomutase 2-like 1 |
| chr19_-_7293942 | 5.81 |
ENST00000341500.5
ENST00000302850.5 |
INSR
|
insulin receptor |
| chr4_-_99579733 | 5.78 |
ENST00000305798.3
|
TSPAN5
|
tetraspanin 5 |
| chr2_+_148602058 | 5.71 |
ENST00000241416.7
ENST00000535787.1 ENST00000404590.1 |
ACVR2A
|
activin A receptor, type IIA |
| chr11_-_129062093 | 5.68 |
ENST00000310343.9
|
ARHGAP32
|
Rho GTPase activating protein 32 |
| chr9_-_3525968 | 5.67 |
ENST00000382004.3
ENST00000302303.1 ENST00000449190.1 |
RFX3
|
regulatory factor X, 3 (influences HLA class II expression) |
| chr9_-_138799070 | 5.66 |
ENST00000389532.4
ENST00000409386.3 |
CAMSAP1
|
calmodulin regulated spectrin-associated protein 1 |
| chr2_+_231902193 | 5.65 |
ENST00000373640.4
|
C2orf72
|
chromosome 2 open reading frame 72 |
| chr22_+_31742875 | 5.63 |
ENST00000504184.2
|
AC005003.1
|
CDNA FLJ20464 fis, clone KAT06158; HCG1777549; Uncharacterized protein |
| chr1_+_113615794 | 5.56 |
ENST00000361127.5
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2 |
| chr4_+_106629929 | 5.54 |
ENST00000512828.1
ENST00000394730.3 ENST00000507281.1 ENST00000515279.1 |
GSTCD
|
glutathione S-transferase, C-terminal domain containing |
| chr3_-_56502375 | 5.52 |
ENST00000288221.6
|
ERC2
|
ELKS/RAB6-interacting/CAST family member 2 |
| chr20_+_48429356 | 5.51 |
ENST00000361573.2
ENST00000541138.1 ENST00000539601.1 |
SLC9A8
|
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 |
| chr1_+_18958008 | 5.45 |
ENST00000420770.2
ENST00000400661.3 |
PAX7
|
paired box 7 |
| chr4_-_90229142 | 5.43 |
ENST00000609438.1
|
GPRIN3
|
GPRIN family member 3 |
| chr3_-_123603137 | 5.40 |
ENST00000360304.3
ENST00000359169.1 ENST00000346322.5 ENST00000360772.3 |
MYLK
|
myosin light chain kinase |
| chr13_+_42846272 | 5.37 |
ENST00000025301.2
|
AKAP11
|
A kinase (PRKA) anchor protein 11 |
| chr19_+_49622646 | 5.36 |
ENST00000334186.4
|
PPFIA3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
| chr10_+_104678032 | 5.35 |
ENST00000369878.4
ENST00000369875.3 |
CNNM2
|
cyclin M2 |
| chr9_-_27529726 | 5.27 |
ENST00000262244.5
|
MOB3B
|
MOB kinase activator 3B |
| chr14_-_100070363 | 5.25 |
ENST00000380243.4
|
CCDC85C
|
coiled-coil domain containing 85C |
| chr1_+_27561007 | 5.24 |
ENST00000319394.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
| chr10_+_88718397 | 5.22 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr12_-_65515334 | 5.22 |
ENST00000286574.4
|
WIF1
|
WNT inhibitory factor 1 |
| chr6_-_99873145 | 5.20 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
| chr6_+_151561085 | 5.20 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
| chr17_+_77751931 | 5.14 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
| chr9_+_131843377 | 5.13 |
ENST00000372546.4
ENST00000406974.3 ENST00000540102.1 |
DOLPP1
|
dolichyldiphosphatase 1 |
| chr17_-_40897043 | 5.10 |
ENST00000428826.2
ENST00000592492.1 ENST00000585893.1 ENST00000593214.1 ENST00000590078.1 ENST00000586382.1 ENST00000415827.2 ENST00000592743.1 ENST00000586089.1 ENST00000435174.1 |
EZH1
|
enhancer of zeste homolog 1 (Drosophila) |
| chr15_+_41245160 | 5.08 |
ENST00000444189.2
ENST00000446533.3 |
CHAC1
|
ChaC, cation transport regulator homolog 1 (E. coli) |
| chr3_+_47324424 | 5.03 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
| chr10_-_104474128 | 4.95 |
ENST00000260746.5
|
ARL3
|
ADP-ribosylation factor-like 3 |
| chr5_-_95297678 | 4.95 |
ENST00000237853.4
|
ELL2
|
elongation factor, RNA polymerase II, 2 |
| chr3_-_178790057 | 4.94 |
ENST00000311417.2
|
ZMAT3
|
zinc finger, matrin-type 3 |
| chr11_+_33278811 | 4.85 |
ENST00000303296.4
ENST00000379016.3 |
HIPK3
|
homeodomain interacting protein kinase 3 |
| chr20_-_34287259 | 4.84 |
ENST00000397425.1
ENST00000540053.1 ENST00000541387.1 ENST00000374092.4 |
NFS1
|
NFS1 cysteine desulfurase |
| chr5_+_177557997 | 4.78 |
ENST00000313386.4
ENST00000515098.1 ENST00000542098.1 ENST00000502814.1 ENST00000507457.1 ENST00000508647.1 |
RMND5B
|
required for meiotic nuclear division 5 homolog B (S. cerevisiae) |
| chr3_-_114790179 | 4.72 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
| chr12_+_125478241 | 4.66 |
ENST00000341446.8
|
BRI3BP
|
BRI3 binding protein |
| chr17_-_4607335 | 4.64 |
ENST00000570571.1
ENST00000575101.1 ENST00000436683.2 ENST00000574876.1 |
PELP1
|
proline, glutamate and leucine rich protein 1 |
| chr13_-_41240717 | 4.63 |
ENST00000379561.5
|
FOXO1
|
forkhead box O1 |
| chr9_-_116163400 | 4.62 |
ENST00000277315.5
ENST00000448137.1 ENST00000409155.3 |
ALAD
|
aminolevulinate dehydratase |
| chr5_+_140165876 | 4.58 |
ENST00000504120.2
ENST00000394633.3 ENST00000378133.3 |
PCDHA1
|
protocadherin alpha 1 |
| chr9_+_130374537 | 4.48 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
| chr17_-_72889697 | 4.48 |
ENST00000310226.6
|
FADS6
|
fatty acid desaturase 6 |
| chr20_+_49348081 | 4.47 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
| chr1_-_40157345 | 4.47 |
ENST00000372844.3
|
HPCAL4
|
hippocalcin like 4 |
| chr3_-_66551351 | 4.47 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
| chr3_-_49907323 | 4.45 |
ENST00000296471.7
ENST00000488336.1 ENST00000467248.1 ENST00000466940.1 ENST00000463537.1 ENST00000480398.2 |
CAMKV
|
CaM kinase-like vesicle-associated |
| chr9_+_140100113 | 4.43 |
ENST00000371521.4
ENST00000344894.5 ENST00000427047.2 ENST00000458322.2 |
NDOR1
|
NADPH dependent diflavin oxidoreductase 1 |
| chr6_+_32121218 | 4.40 |
ENST00000414204.1
ENST00000361568.2 ENST00000395523.1 |
PPT2
|
palmitoyl-protein thioesterase 2 |
| chr7_-_14029515 | 4.39 |
ENST00000430479.1
ENST00000405218.2 ENST00000343495.5 |
ETV1
|
ets variant 1 |
| chr17_-_8093471 | 4.38 |
ENST00000389017.4
|
C17orf59
|
chromosome 17 open reading frame 59 |
| chr7_-_143105941 | 4.37 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr9_+_34179003 | 4.34 |
ENST00000545103.1
ENST00000543944.1 ENST00000536252.1 ENST00000540348.1 ENST00000297661.4 ENST00000379186.4 |
UBAP1
|
ubiquitin associated protein 1 |
| chr5_-_54830784 | 4.32 |
ENST00000264775.5
|
PPAP2A
|
phosphatidic acid phosphatase type 2A |
| chr7_-_138666053 | 4.32 |
ENST00000440172.1
ENST00000422774.1 |
KIAA1549
|
KIAA1549 |
| chr1_+_203274639 | 4.30 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
| chr1_-_208417620 | 4.28 |
ENST00000367033.3
|
PLXNA2
|
plexin A2 |
| chr17_-_33416231 | 4.26 |
ENST00000584655.1
ENST00000447669.2 ENST00000315249.7 |
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
| chr14_+_23775971 | 4.26 |
ENST00000250405.5
|
BCL2L2
|
BCL2-like 2 |
| chr14_+_24867992 | 4.24 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr3_+_121903181 | 4.20 |
ENST00000498619.1
|
CASR
|
calcium-sensing receptor |
| chr8_+_120885949 | 4.18 |
ENST00000523492.1
ENST00000286234.5 |
DEPTOR
|
DEP domain containing MTOR-interacting protein |
| chrX_+_10124977 | 4.16 |
ENST00000380833.4
|
CLCN4
|
chloride channel, voltage-sensitive 4 |
| chr19_-_14316980 | 4.16 |
ENST00000361434.3
ENST00000340736.6 |
LPHN1
|
latrophilin 1 |
| chr2_+_168725458 | 4.15 |
ENST00000392690.3
|
B3GALT1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
| chr7_-_994302 | 4.14 |
ENST00000265846.5
|
ADAP1
|
ArfGAP with dual PH domains 1 |
| chr16_+_57769635 | 4.13 |
ENST00000379661.3
ENST00000562592.1 ENST00000566726.1 |
KATNB1
|
katanin p80 (WD repeat containing) subunit B 1 |
| chr5_+_139493665 | 4.13 |
ENST00000331327.3
|
PURA
|
purine-rich element binding protein A |
| chr2_+_173940442 | 4.13 |
ENST00000409176.2
ENST00000338983.3 ENST00000431503.2 |
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
| chr1_-_92351769 | 4.13 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
| chr17_+_25799008 | 4.12 |
ENST00000583370.1
ENST00000398988.3 ENST00000268763.6 |
KSR1
|
kinase suppressor of ras 1 |
| chr9_+_132934835 | 4.10 |
ENST00000372398.3
|
NCS1
|
neuronal calcium sensor 1 |
| chr10_+_99344104 | 4.10 |
ENST00000555577.1
ENST00000370649.3 |
PI4K2A
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha Phosphatidylinositol 4-kinase type 2-alpha; Uncharacterized protein |
| chr11_-_119599794 | 4.09 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
| chr8_-_82024290 | 4.08 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
| chr12_-_96794143 | 4.04 |
ENST00000543119.2
|
CDK17
|
cyclin-dependent kinase 17 |
| chr3_+_138066539 | 4.04 |
ENST00000289104.4
|
MRAS
|
muscle RAS oncogene homolog |
| chr3_+_14989076 | 4.00 |
ENST00000413118.1
ENST00000425241.1 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
| chr6_+_157802165 | 3.99 |
ENST00000414563.2
ENST00000359775.5 |
ZDHHC14
|
zinc finger, DHHC-type containing 14 |
| chr12_+_10365404 | 3.97 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
| chr12_+_69864129 | 3.96 |
ENST00000547219.1
ENST00000299293.2 ENST00000549921.1 ENST00000550316.1 ENST00000548154.1 ENST00000547414.1 ENST00000550389.1 ENST00000550937.1 ENST00000549092.1 ENST00000550169.1 |
FRS2
|
fibroblast growth factor receptor substrate 2 |
| chr2_+_166095898 | 3.96 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
| chr4_+_72204755 | 3.96 |
ENST00000512686.1
ENST00000340595.3 |
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
| chr13_-_28674693 | 3.95 |
ENST00000537084.1
ENST00000241453.7 ENST00000380982.4 |
FLT3
|
fms-related tyrosine kinase 3 |
| chr12_+_57943781 | 3.88 |
ENST00000455537.2
ENST00000286452.5 |
KIF5A
|
kinesin family member 5A |
| chr10_+_103113802 | 3.88 |
ENST00000370187.3
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase |
| chr8_+_79578282 | 3.86 |
ENST00000263849.4
|
ZC2HC1A
|
zinc finger, C2HC-type containing 1A |
| chr13_-_21476900 | 3.86 |
ENST00000400602.2
ENST00000255305.6 |
XPO4
|
exportin 4 |
| chr5_-_160279207 | 3.86 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
| chr11_-_86666427 | 3.84 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
| chr5_+_140261703 | 3.83 |
ENST00000409494.1
ENST00000289272.2 |
PCDHA13
|
protocadherin alpha 13 |
| chr1_-_155532484 | 3.81 |
ENST00000368346.3
ENST00000548830.1 |
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila) |
| chr15_+_59063478 | 3.78 |
ENST00000559228.1
ENST00000450403.2 |
FAM63B
|
family with sequence similarity 63, member B |
| chr7_-_98741642 | 3.78 |
ENST00000361368.2
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
| chr9_-_136857403 | 3.77 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
| chr3_+_38495333 | 3.76 |
ENST00000352511.4
|
ACVR2B
|
activin A receptor, type IIB |
| chr8_-_93115445 | 3.74 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr13_-_30424821 | 3.71 |
ENST00000380680.4
|
UBL3
|
ubiquitin-like 3 |
| chr13_-_28545276 | 3.70 |
ENST00000381020.7
|
CDX2
|
caudal type homeobox 2 |
| chr12_+_7342178 | 3.70 |
ENST00000266563.5
ENST00000543974.1 |
PEX5
|
peroxisomal biogenesis factor 5 |
| chr9_+_92219919 | 3.70 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
| chr12_-_12419703 | 3.67 |
ENST00000543091.1
ENST00000261349.4 |
LRP6
|
low density lipoprotein receptor-related protein 6 |
| chr13_+_113622810 | 3.58 |
ENST00000397030.1
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
| chr3_+_49977440 | 3.58 |
ENST00000442092.1
ENST00000266022.4 ENST00000443081.1 |
RBM6
|
RNA binding motif protein 6 |
| chr14_-_50698276 | 3.57 |
ENST00000216373.5
|
SOS2
|
son of sevenless homolog 2 (Drosophila) |
| chr8_+_23430157 | 3.55 |
ENST00000399967.3
|
FP15737
|
FP15737 |
| chr12_+_54402790 | 3.53 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
| chr19_+_4304632 | 3.50 |
ENST00000597590.1
|
FSD1
|
fibronectin type III and SPRY domain containing 1 |
| chr17_-_27916621 | 3.50 |
ENST00000225394.3
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1 |
| chr17_-_42580738 | 3.50 |
ENST00000585614.1
ENST00000591680.1 ENST00000434000.1 ENST00000588554.1 ENST00000592154.1 |
GPATCH8
|
G patch domain containing 8 |
Network of associatons between targets according to the STRING database.
First level regulatory network of AGCAGCA
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 20.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 3.7 | 14.8 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 3.5 | 10.6 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 2.6 | 10.5 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 2.6 | 7.9 | GO:1904647 | response to rotenone(GO:1904647) |
| 2.5 | 7.5 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 2.4 | 11.8 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 2.3 | 9.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 2.3 | 6.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 2.1 | 6.2 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 2.1 | 6.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 2.0 | 12.0 | GO:0051013 | microtubule severing(GO:0051013) |
| 2.0 | 17.6 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 1.9 | 5.7 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 1.9 | 9.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.9 | 5.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 1.8 | 9.1 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 1.7 | 6.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 1.6 | 4.8 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 1.5 | 10.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 1.5 | 4.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.5 | 5.8 | GO:0019086 | late viral transcription(GO:0019086) |
| 1.5 | 5.8 | GO:1990535 | transformation of host cell by virus(GO:0019087) neuron projection maintenance(GO:1990535) |
| 1.4 | 7.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 1.4 | 7.2 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.4 | 7.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.4 | 10.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 1.4 | 9.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 1.4 | 4.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.4 | 5.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 1.3 | 12.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.3 | 4.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 1.3 | 3.9 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.3 | 3.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 1.2 | 3.7 | GO:0090244 | trachea cartilage morphogenesis(GO:0060535) Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 1.2 | 12.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 1.2 | 4.6 | GO:1902617 | response to fluoride(GO:1902617) |
| 1.1 | 1.1 | GO:1902285 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 1.1 | 3.4 | GO:0003285 | septum secundum development(GO:0003285) |
| 1.1 | 4.5 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 1.0 | 3.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 1.0 | 3.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.9 | 10.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.9 | 3.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.9 | 5.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.9 | 2.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.9 | 2.6 | GO:0021966 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) corticospinal neuron axon guidance(GO:0021966) regulation of negative chemotaxis(GO:0050923) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.8 | 3.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.8 | 2.5 | GO:1903401 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transmembrane transport(GO:1903401) L-lysine import into cell(GO:1903410) |
| 0.8 | 3.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.8 | 5.6 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.8 | 8.6 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.7 | 2.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.7 | 3.7 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.7 | 9.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.7 | 2.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 | 7.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.7 | 11.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.7 | 3.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.7 | 15.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.6 | 2.5 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.6 | 5.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.6 | 19.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.6 | 0.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.6 | 2.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.6 | 4.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.6 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.6 | 6.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.5 | 4.4 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.5 | 1.1 | GO:0021586 | pons maturation(GO:0021586) |
| 0.5 | 2.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.5 | 9.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.5 | 83.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.5 | 1.6 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.5 | 4.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.5 | 2.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.5 | 1.5 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.5 | 3.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.5 | 2.4 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.5 | 2.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.5 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.5 | 2.8 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.5 | 1.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.4 | 4.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.4 | 0.9 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 7.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.4 | 0.9 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.4 | 4.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.4 | 0.4 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.4 | 1.3 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.4 | 1.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.4 | 4.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 | 0.4 | GO:0032900 | negative regulation of neurotrophin production(GO:0032900) |
| 0.4 | 1.2 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.4 | 2.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 | 5.4 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.4 | 1.5 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.4 | 3.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.4 | 3.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.3 | 2.8 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.3 | 1.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.3 | 2.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.3 | 2.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.3 | 5.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.3 | 5.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.3 | 2.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 2.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 1.3 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.3 | 3.0 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.3 | 1.3 | GO:0001757 | somite specification(GO:0001757) |
| 0.3 | 1.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 | 2.9 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.3 | 2.5 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.3 | 8.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 | 2.8 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.3 | 0.6 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.3 | 3.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.3 | 4.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.3 | 2.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 | 4.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.3 | 1.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.3 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 2.9 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 | 4.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.3 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 2.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.3 | 4.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.3 | 1.4 | GO:1903971 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.3 | 3.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 4.0 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.3 | 3.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.3 | 2.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.3 | 4.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.3 | 1.0 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
| 0.3 | 1.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.3 | 6.9 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.3 | 6.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 2.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.3 | 0.8 | GO:0033341 | regulation of collagen binding(GO:0033341) response to L-ascorbic acid(GO:0033591) |
| 0.2 | 4.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 2.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 2.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 | 2.4 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.2 | 2.8 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.2 | 1.2 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 | 5.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.2 | 0.9 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.2 | 2.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 3.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.2 | 3.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 | 0.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 | 1.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 13.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.2 | 8.5 | GO:0090102 | cochlea development(GO:0090102) |
| 0.2 | 2.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 3.4 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 | 1.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 2.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.2 | 4.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 1.1 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.2 | 2.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.2 | 0.8 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 | 3.2 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 0.2 | 0.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 3.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.8 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.2 | 3.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 | 10.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
| 0.2 | 1.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 3.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.2 | 7.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
| 0.2 | 4.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.2 | 12.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.2 | 1.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 2.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.2 | 3.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.2 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.2 | 1.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 | 5.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 1.3 | GO:0001955 | blood vessel maturation(GO:0001955) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 2.6 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 | 1.8 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 | 5.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 | 2.3 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.2 | 3.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.2 | 1.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 | 1.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.2 | 1.4 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.2 | 1.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.2 | 2.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 | 2.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 | 1.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 1.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.1 | 3.9 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 1.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 0.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 1.7 | GO:0035372 | protein localization to microtubule(GO:0035372) cellular response to histamine(GO:0071420) |
| 0.1 | 1.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 3.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 3.2 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 1.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 | 2.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 5.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.1 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 2.9 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 5.3 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.1 | 1.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.1 | 0.8 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.1 | 1.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 1.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 | 0.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 2.3 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.1 | 2.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 5.9 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.1 | 4.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 3.0 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 6.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.1 | 2.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.1 | 3.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 1.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.1 | 0.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.1 | 2.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 2.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 11.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 | 0.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 3.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.1 | 0.8 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 1.1 | GO:0060348 | bone development(GO:0060348) |
| 0.1 | 2.0 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 4.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 | 0.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 | 1.2 | GO:0008344 | adult locomotory behavior(GO:0008344) |
| 0.1 | 1.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 4.5 | GO:0007417 | central nervous system development(GO:0007417) |
| 0.1 | 7.0 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
| 0.1 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 5.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 1.6 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 2.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 2.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 1.0 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.1 | 3.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 1.9 | GO:0021766 | hippocampus development(GO:0021766) |
| 0.1 | 2.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.1 | 2.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 14.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.1 | 3.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 2.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 2.4 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) |
| 0.1 | 2.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.1 | 2.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.0 | 0.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 | 1.5 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
| 0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.0 | 1.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 1.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 1.0 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.0 | 1.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 2.8 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.0 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 1.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.0 | 0.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 1.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 | 0.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 1.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 2.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 | 0.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 3.8 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
| 0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 1.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 | 3.5 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 3.4 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 | 0.8 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.0 | 0.9 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.0 | 0.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 | 0.9 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 0.7 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
| 0.0 | 0.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.4 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 1.3 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.0 | 2.6 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 | 1.6 | GO:0031638 | zymogen activation(GO:0031638) |
| 0.0 | 1.4 | GO:0006874 | cellular calcium ion homeostasis(GO:0006874) cellular divalent inorganic cation homeostasis(GO:0072503) |
| 0.0 | 2.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 3.4 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.0 | 1.2 | GO:0006006 | glucose metabolic process(GO:0006006) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.0 | 20.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 3.5 | 10.4 | GO:0044305 | calyx of Held(GO:0044305) |
| 2.7 | 10.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 2.5 | 9.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.6 | 4.8 | GO:0034657 | GID complex(GO:0034657) |
| 1.6 | 20.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 1.4 | 5.6 | GO:0035838 | growing cell tip(GO:0035838) |
| 1.3 | 9.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 1.2 | 7.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 1.2 | 3.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.2 | 9.4 | GO:0071204 | U7 snRNP(GO:0005683) histone pre-mRNA 3'end processing complex(GO:0071204) |
| 1.1 | 4.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.0 | 3.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 1.0 | 2.9 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.9 | 10.8 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.9 | 2.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) outer acrosomal membrane(GO:0002081) |
| 0.8 | 5.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.7 | 11.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.6 | 17.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.6 | 2.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.5 | 5.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.5 | 8.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.5 | 2.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.4 | 7.2 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.4 | 2.5 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.4 | 9.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.4 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.4 | 1.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.3 | 14.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.3 | 3.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.3 | 3.7 | GO:0044438 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.3 | 2.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 4.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 4.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.3 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.3 | 3.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.3 | 9.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.3 | 8.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.3 | 19.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.3 | 3.2 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 3.7 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.3 | 2.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.3 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.3 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 10.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 9.8 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.2 | 1.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.2 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 4.1 | GO:0031045 | dense core granule(GO:0031045) |
| 0.2 | 2.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 1.0 | GO:0097550 | male pronucleus(GO:0001940) transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 7.2 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 31.9 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.2 | 1.5 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 3.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 6.0 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.2 | 0.5 | GO:0031213 | RSF complex(GO:0031213) |
| 0.2 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.2 | 1.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.1 | 5.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.1 | 6.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 18.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.1 | 2.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 1.0 | GO:0044294 | dendrite terminus(GO:0044292) dendritic growth cone(GO:0044294) |
| 0.1 | 6.9 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 15.2 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 15.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.1 | 8.0 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.1 | 3.9 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 2.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 3.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.1 | 5.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 2.9 | GO:0030120 | vesicle coat(GO:0030120) |
| 0.1 | 12.5 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 0.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 2.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 5.0 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 2.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 11.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 2.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 2.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 1.6 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 4.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 6.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 1.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 6.3 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 3.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 7.4 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 8.3 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 8.2 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 3.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.8 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 97.3 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.1 | 2.9 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.1 | 6.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 0.7 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 6.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 2.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 2.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 2.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 5.3 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 1.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.0 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 5.2 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 6.4 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 2.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.9 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 1.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 12.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 3.5 | 10.6 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 3.1 | 9.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 3.0 | 12.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 2.5 | 7.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 2.4 | 7.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 2.3 | 6.9 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 2.1 | 6.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 2.0 | 12.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 1.8 | 7.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.4 | 7.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 1.4 | 5.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 1.4 | 4.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 1.4 | 4.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.4 | 9.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 1.3 | 13.1 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.2 | 13.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 1.2 | 10.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 1.2 | 3.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 1.1 | 9.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 1.1 | 35.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 1.1 | 4.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 1.1 | 5.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 1.0 | 32.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 1.0 | 3.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 1.0 | 5.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.0 | 2.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 1.0 | 1.0 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 1.0 | 5.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.9 | 7.4 | GO:0043559 | insulin binding(GO:0043559) |
| 0.9 | 3.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.9 | 3.4 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.8 | 2.5 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.7 | 3.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.7 | 2.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.7 | 4.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.7 | 3.3 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.6 | 2.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.6 | 3.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.6 | 1.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.6 | 4.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.5 | 4.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.5 | 4.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.5 | 2.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.5 | 2.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.5 | 6.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.5 | 10.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.5 | 4.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.5 | 2.9 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.5 | 2.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.5 | 5.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.5 | 2.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.4 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.4 | 6.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.4 | 4.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.4 | 2.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.4 | 2.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.4 | 2.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.4 | 1.3 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.4 | 4.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.4 | 2.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.4 | 9.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.4 | 4.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.4 | 2.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.4 | 7.9 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
| 0.4 | 5.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.4 | 5.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.4 | 4.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.4 | 3.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.3 | 1.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.3 | 4.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 3.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 3.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.3 | 1.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.3 | 9.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.3 | 17.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 4.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.3 | 4.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.3 | 2.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.3 | 1.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.3 | 2.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.3 | 0.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 4.0 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.3 | 1.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 4.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.3 | 2.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.3 | 2.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.3 | 1.3 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 3.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.2 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 1.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 2.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 4.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 3.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.2 | 4.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 1.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.2 | 0.8 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.2 | 2.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.2 | 0.8 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.2 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 3.7 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 1.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 2.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.2 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.2 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 3.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 0.8 | GO:0070905 | serine binding(GO:0070905) |
| 0.2 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.1 | 10.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 1.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 2.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 4.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 3.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 5.3 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 3.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 3.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 1.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 4.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 15.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 5.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 11.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.1 | 5.7 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 4.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 2.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 7.7 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 2.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 2.9 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 5.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.1 | 2.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 1.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 2.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 2.9 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 6.2 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.1 | 2.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 0.1 | 1.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 3.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 2.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 2.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.1 | 6.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 60.4 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.1 | 1.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 1.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 2.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 1.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 2.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 1.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 1.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 2.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 3.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.1 | 8.7 | GO:0004519 | endonuclease activity(GO:0004519) |
| 0.1 | 8.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 7.7 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 9.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 1.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 5.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.1 | 5.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 3.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 1.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 5.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.0 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 1.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 6.8 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
| 0.0 | 7.0 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.6 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 1.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) sequence-specific mRNA binding(GO:1990825) |
| 0.0 | 1.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 1.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 2.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 1.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 2.6 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
| 0.0 | 0.4 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.0 | 0.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 1.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 2.8 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.0 | 4.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 4.0 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 5.7 | GO:0022890 | inorganic cation transmembrane transporter activity(GO:0022890) |
| 0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 3.2 | GO:0003823 | antigen binding(GO:0003823) |
| 0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.0 | 1.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 3.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 19.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.6 | 18.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.5 | 4.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.5 | 19.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 2.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.3 | 4.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.2 | 5.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 14.7 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 9.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 6.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 2.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 4.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 2.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 2.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 5.0 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 6.1 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 3.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 3.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 3.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 5.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 2.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 17.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 4.4 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 5.5 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 7.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 4.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 3.4 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 3.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 2.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 4.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 2.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 4.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 2.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 0.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 0.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 2.2 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 3.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 1.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 1.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 15.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.4 | 24.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.7 | 15.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.6 | 9.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.6 | 0.6 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
| 0.6 | 8.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.5 | 7.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.4 | 6.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.4 | 3.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.4 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.4 | 10.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.4 | 7.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 3.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.3 | 8.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.3 | 9.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 10.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.3 | 5.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.3 | 5.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 7.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.3 | 1.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.3 | 1.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.3 | 2.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 29.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 7.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 4.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.2 | 2.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.2 | 9.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.2 | 6.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 5.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.2 | 8.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 3.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.2 | 3.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 3.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 4.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 6.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.2 | 2.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 9.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 4.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 5.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 3.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.1 | 1.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 6.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 2.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 3.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 4.5 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 8.5 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
| 0.1 | 2.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 3.3 | REACTOME AXON GUIDANCE | Genes involved in Axon guidance |
| 0.1 | 5.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 2.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 2.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 2.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 8.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 3.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 2.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 1.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 1.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 0.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.0 | 1.5 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.0 | 2.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 2.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 2.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 0.8 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 1.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 0.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
| 0.0 | 0.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |